breast cancer right icd 10

Release time ：Nov-17,2024

Breast cancer is one of the most prevalent malignant neoplasms among women, classified under ICD-10 code C50. Its incidence is on the rise, posing a significant threat to women's health. Treatment strategies for breast cancer must take into account various factors including the patient's age, disease stage, and histological subtype. Common therapeutic approaches encompass surgery, radiotherapy, chemotherapy, and endocrine therapy.

For early-stage breast cancer patients, surgery is often the primary treatment option. Depending on the tumor's location and size, either breast-conserving surgery or total mastectomy may be selected. Post-breast-conserving surgery, radiotherapy is typically administered to minimize the risk of local recurrence. For patients with intermediate to advanced breast cancer, chemotherapy is a principal therapeutic modality. It can reduce tumor size, enhance the likelihood of complete surgical removal, and eradicate micrometastatic deposits, thereby reducing the risk of relapse. Furthermore, for patients with hormone receptor-positive breast cancer, endocrine therapy is a crucial treatment, with medications such as tamoxifen and anastrozole being frequently utilized.

In the case of HER2-positive breast cancer patients, targeted therapy is indispensable. Trastuzumab and pertuzumab are among the commonly employed targeted agents. It is important to recognize that breast cancer treatment should be tailored to the individual, with different patients potentially requiring distinct treatment regimens. Consequently, patients must adhere to their physician's recommendations, undergo regular follow-ups to facilitate timely adjustments to their treatment plan. Additionally, maintaining healthy lifestyle practices, such as abstaining from smoking and limiting alcohol consumption, maintaining a balanced diet, and engaging in moderate physical activity, can contribute to improved therapeutic outcomes and a reduced risk of recurrence.